Bill > HB928

This bill updates Pennsylvania's laws regarding epinephrine delivery systems, expanding their availability and usage across various entities. The legislation modifies definitions and provisions related to epinephrine devices, replacing the term "auto-injector" with "delivery system" and broadening the list of authorized entities that can obtain and use these devices. The bill specifically adds day-care facilities to the list of entities that can acquire and stock epinephrine delivery systems, mandating that they do so when funding is available. It requires designated employees to complete a comprehensive anaphylaxis training program covering recognition of severe allergic reactions, proper storage and administration of the device, and emergency follow-up procedures. The bill also mandates that the state develop informational materials for day-care facilities to distribute to parents about allergic reactions and the new requirements. Importantly, the legislation provides legal protection (Good Samaritan provisions) for entities, healthcare practitioners, and individuals who in good faith administer or facilitate the use of epinephrine delivery systems, as long as their actions do not constitute intentional misconduct or gross negligence. The changes aim to improve emergency response capabilities and increase access to life-saving allergy treatment in various public and professional settings. The law will take effect 180 days after its passage.

Budget and Finance, Education, Health and Social Services

https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2025&sind=0&body=H&type=B&bn=928